Cumberland Pharmaceuticals (CPIX) FCF Margin Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | -257,125.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -257,125.00 |
| Mar 31, 2026 | -2,864.00 |
| Dec 31, 2025 | -1,821.00 |
| Sep 30, 2025 | -309.00 |
| Jun 30, 2025 | 1,630.00 |
| Mar 31, 2025 | 5,851.00 |
| Dec 31, 2024 | 763.00 |
| Sep 30, 2024 | -667.00 |
| Jun 30, 2024 | -5,618.00 |
| Mar 31, 2024 | -910.00 |
| Dec 31, 2023 | -3,096.00 |
| Sep 30, 2023 | -1,056.00 |
| Jun 30, 2023 | 2,612.00 |
| Mar 31, 2023 | -1,495.00 |
| Dec 31, 2022 | 19.00 |
| Sep 30, 2022 | 4,277.00 |
| Jun 30, 2022 | -835.00 |
| Mar 31, 2022 | -1,835.00 |
| Dec 31, 2021 | 3,349.00 |
| Sep 30, 2021 | -4,409.00 |